News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


PHARMAC agrees funding for brain tumour treatment

3 April 2006

PHARMAC agrees funding for brain tumour treatment

A new treatment for people with an aggressive form of brain tumour is to become fully subsidised from 1 May 2006.

Funding for temozolomide (Temodal) has been approved by PHARMAC for patients who are undergoing radiotherapy, and for a further six cycles of treatment following radiotherapy. Funding will be for newly diagnosed patients, and for those patients who may have already commenced treatment before 1 May 2006, and is anticipated to cost $6.5 million over five years.

About 100 patients per year are expected to receive funded access.

PHARMAC Medical Director Dr Peter Moodie says for those patients diagnosed with glioblastoma multiforme, the most aggressive form of brain tumour, temozolomide offers a beneficial treatment that can extend their life expectancy.

“The evidence shows that this is a treatment that can extend life, and we are pleased to be able to fund it,” Dr Moodie says.

“PHARMAC and its expert clinical committees looked very carefully at the evidence. It shows that temozolomide can make a difference for patients who have temozolomide with radiotherapy in the early stages after diagnosis, and this is why it is those patients who will receive funding.”

Though analysis shows that temozolomide is less cost-effective than some other medicines PHARMAC is looking at funding, the listing is justified on other grounds such as the limited treatment options for brain tumour patients.

Funding does not extend to patients with relapsed glioblastomas, however PHARMAC remains open to the possibility of funding temozolomide for relapsed patients should new evidence become available.

Dr Moodie acknowledged the co-operation of temozolomide’s supplier Schering-Plough, which had worked constructively with PHARMAC to move quickly through the application, assessment and subsidy process.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Scoop Review Of Books: Almost Getting Away With Murder

The Black Widow by Lee-Anne Cartier: Lee-Anne Cartier is the sister of the Christchurch man found to have been murdered by his wife, Helen Milner, after an initial assumption by police that his death, in 2009, was suicide. More>>

Howard Davis: Triple Echo - The Malevich/Reinhardt/Hotere Nexus

Howard Davis: The current juxtaposition of works by Ralph Hotere and Ad Reinhardt at Te Papa perfectly exemplifies Jean Michel Massing's preoccupation with the transmigration of imagery in a remarkable triple echo effect... More>>

Scoop Review Of Books: Nō Tāu Manawa

Vaughan Rapatahana responds to Fale Aitu | Spirit House by Tusiata Avi.

9 Golds - 21 Medals: NZ Team Celebrates As Rio 2016 Paralympic Games Close

The entire New Zealand Paralympic Team, led by kiwi sprinter and double gold medallist Liam Malone as flag bearer, are on the bus to the Maracanã Stadium in Rio de Janeiro for the Closing Ceremony of the Rio 2016 Paralympic Games. There, they will celebrate the fantastic successes of the past 10 days. More>>


New Zealand Improv Festival: The Festival Of Moments To Return To The Capital

The eighth incarnation of the New Zealand Improv Festival comes to BATS Theatre this 4-8 October , with a stellar line-up of spontaneous theatre and instant comedy performed and directed by top improvisors from around New Zealand and the world. More>>


CDF Tim Keating: NZ Somme Centenary

"Our generals also knew what to expect, and they built that knowledge into their planning. Each of the four set-piece attacks was fought with a single brigade, with the expectation that the brigade would be used up. A fresh brigade would then be brought up to conduct the next set-piece..." More>>


Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news